You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TEVA Sale Disclosure
Lippman Evan · SEC Form 4 · Filed Aug 19, 2026
Sale
Calculated transaction value
$680.29K
Lippman Evan EVP, Business Development
TEVA
Transaction date
Aug 17, 2026
Public filing date
Aug 19, 2026
Filing lag
Filed 2 days later
TEVA daily price context
Close on/before transaction
$36.46
Aug 17, 2026
First close after public filing
$36.81
Aug 20, 2026
30-day return after filing
+5.9%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 18,600 shares @ $36.57
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-356853
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$680.29K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd TEVA Current | Sale | Aug 17, 2026 | $680.29K |